The total number of scientific publications in pharmaceutical science in the United States has shown varied trends from 2013 to 2023. In 2023, the publications stood at 1.7 thousand, with year-on-year growth recorded at 0.22%. Over the past decade, the industry experienced fluctuations, with significant declines observed between 2016 to 2020. Notably, 2021 saw a resurgence with a 14.74% increase, followed by stabilizing figures through to 2023. The Compound Annual Growth Rate (CAGR) over the last five years is 1.94%, indicating modest growth.
Forecasted data from 2024 to 2028 suggests a stable trend with minimal growth, reflected in a 5-year forecasted CAGR of 0.08% and a forecasted 5-year growth rate of 0.42%. This stabilization signals a maturation phase in pharmaceutical science publications.
Future trends to watch for include:
- Further advancements in biopharmaceutical research.
- Increasing interdisciplinary publications incorporating AI and biotechnology.
- The impact of regulatory changes on publication frequency.
- Collaboration trends between academia and industry impacting publication volumes.
- Shifts in funding and investment affecting research output.
